Generic Name: thioureidobutyronitrile Trade Name
Post# of 72436
![](/assets/46931549/no_avatar_available_thumb.jpg)
Trade Name: Kevetrin
Date Designated: 11/17/2015
Orphan Designation: Treatment of retinoblastoma.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Sponsor: Cellceutix Corporation
100 Cummings Center
Suite 151-B
Beverly, Massachusetts 01915
The sponsor address listed is the last reported by the sponsor to OOPD.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)